GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » Other Income (Expense)

SynBiotic SE (XTER:SBX) Other Income (Expense) : €-0.74 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is SynBiotic SE Other Income (Expense)?

SynBiotic SE's other income expense for the SynBiotic SE's pretax income for the six months ended in Dec. 2023 was €0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.74 Mil.

SynBiotic SE Other Income (Expense) Historical Data

The historical data trend for SynBiotic SE's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynBiotic SE Other Income (Expense) Chart

SynBiotic SE Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial - -0.14 -1.60 -0.74 -0.55

SynBiotic SE Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only - -1.60 - -0.74 -

SynBiotic SE Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SynBiotic SE  (XTER:SBX) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

SynBiotic SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » Other Income (Expense)
Comparable Companies
XTER:B8FK ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS SZSE:000538 NBIX BOM:543904 BOM:500124 NSE:TORNTPHARM HKSE:03692 TSE:4507 BOM:500257 CTLT
Traded in Other Exchanges
SBX:Germany
Address
Barer Strasse 7, Munich, BY, DEU, 80333
Website
https://www.synbiotic.com
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.
Executives
Daniel Kruse Geschäftsführender Direktor

SynBiotic SE Headlines

No Headlines